Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund IEH EUR AccRegistrer dig for at låse op for ratings |
Fondens performance | 31-01-2022 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | - | - | 79,8 | 22,1 | -12,3 | |
+/-Kat | - | - | - | - | - | |
+/-Indeks | - | - | - | - | - | |
Kategori: Aktier - Øvrige | ||||||
Kategoribenchmark: - |
Oversigt | ||
Seneste NAV 14-01-2022 | EUR 210,17 | |
Kursændring 1 dag | -0,11% | |
Morningstar Kategori™ | Aktier - Øvrige | |
ISIN | IE00BDB54B39 | |
Markedsværdi i alt (mio.) 17-05-2024 | USD 868,06 | |
Seneste TNA(mio.) 14-01-2022 | EUR 0,06 | |
Emissionstillæg | 3,00% | |
Løbende omkostning 01-01-2024 | 1,40% | |
Investeringsstrategi | Aktiv |
Investeringsmålsætning: Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund IEH EUR Acc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
Jeffrey James 07-12-2016 | ||
Michael Buck 07-12-2016 | ||
Klik her for at se flere | ||
Startdato 25-04-2019 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
Russell Micro Cap Growth TR USD | - |
Target Market | ||||||||||||||||||||
|
Formuefordeling Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund IEH EUR Acc | 31-03-2024 |
|
|
Top 5 placeringer | Sektor | % |
Crinetics Pharmaceuticals Inc | Healthcare | 2,96 |
Modine Manufacturing Co | Cyklisk forbrug | 2,66 |
Camtek Ltd | Teknologi | 2,24 |
FTAI Aviation Ltd | Industri | 2,22 |
Xenon Pharmaceuticals Inc | Healthcare | 1,91 |
Øget Mindsket Ny siden sidste portefølje | ||
Heptagon Fund ICAV - Driehaus US Micro Cap Equity Fund IEH EUR Acc |